The Siglec-8 expression on mRNA level in MCF-7, MDA-MB-231 and T-47D BC cell lines was determined using quantitative real-time (RT)- Polymerase chain reaction (PCR). The
RNeasy Mini Kit (Qiagen, Hilden, Germany) was used to obtain the total RNA from cultured cells. The RNA was converted to cDNA with a
cDNA Synthesis Kit (Biozym 331470L) according to the manufacturer’s instructions. For the RT-PCR, a 20 µL reaction mixture was made up as follows: 1 µL TaqMan
® Gene Expression Assay 20× (Applied Biosystems, Darmstadt, Germany, target GAPDH Nr Hs99999905_m1, target Siglec-8 Nr. Hs00274289_m1, target Gal-7 Nr. Hs00170104_m1, primer sequences are not available due to the use of a commercial assay), 10 µL TaqMan
® Fast Universal PCR Master Mix 2× (Applied Biosystems, Darmstadt, Germany), 1 µL cDNA template and 8 µL RNase free water per sample. RT-PCR was performed on a
96-well plate (Applied Biosystems) covered with an optical adhesive film. A
7500 Fast Real-Time PCR system (Applied Biosystems) was used to run the PCRs. Initially, for the enzyme activation, heating to 95 °C for 20 s was performed, followed by 40 qPCR-cycles of 3 s of denaturation at 95 °C and annealing for 30 s at 60 °C.
Trebo A., Ditsch N., Degenhardt T., Kuhn C., Rahmeh M., Schmoeckel E., Mayr D., Czogalla B., Kolben T., Meister S., Mahner S., Jeschke U, & Hester A. (2021). First Evidence for a Role of Siglec-8 in Breast Cancer. International Journal of Molecular Sciences, 22(4), 2000.